PTEN and neoplasm: In the PTEN-null 786-0 tumour xenografts, there was a significant decrease in tumour 18F-FDG uptake seen following AZD8186 treatment, with a 26 % reduction (p = 0.007) in 18F-FDG uptake observed compared to the vehicle treated group (Fig. 2).